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ABSTRACT 
Reproducibility of Retention Indices Examining Column Type 
Amanda M. Cadau 
Requests for drug analysis accounted for nearly half of all requests (DNA, toxicology, latent 
prints, etc.) submitted to forensic laboratories in the United States (Storm et al., 2010).  A study 
by RTI International found that laboratories are only capable of processing about 80% of their 
controlled substances requests. Based upon this statistic, an estimated 220,000 cases per year 
would be back-logged.  Therefore, tools that can improve the process of seized drug analysis 
would be of use.  This project addresses one such concept, the use of retention indices as a means 
to improve drug screening using gas chromatography/mass spectrometry (GC/MS).  
When drugs that co-elute (such as methamphetamine and phentermine) are analyzed, a mass 
spectrum would not be useful as both substances will give similar spectra.  This presents 
problems especially with designer drugs that are similar in structure and molecular weight.  
Retention index, when coupled with mass spectrometry, can differentiate drugs that co-elute, 
thus reducing false positives and improving screening processes and the reliability of 
identification of compounds with similar mass spectra.   
To date, retention indices have been listed as single whole numbers by providers such as the 
DEA and NIST.  A survey of data obtained from different sources show that is often in 
disagreement between sources for the same compound on the same column.  This is not 
unexpected, but does indicate the need for determination of a realistic range (i.e., uncertainty) 
that should accompany any reported retention index.  In the case of similar compounds, this is 
not just desirable, it is essential.  The goal of this project was to examine factors that could 
contribute to uncertainty (different instruments, different days, etc.), evaluate the relative 
importance of these factors, and to suggest defensible methods for incorporating uncertainty into 
retention index values. 
This study used a DB-5 equivalent column (5% phenyl 95% methylpolysiloxane stationary 
phase) to find the uncertainty range between two different manufactures of gas chromatographs 
and manufacturers of columns.  It was determined that a thinner film afforded the best 
repeatability of RI within the same instrument when concentrations were in the parts-per-million 
range.  It was also determined that with the same experimental parameters and stationary phase 
but varying film thickness, the RI values could not be combined between instruments. The RI 
values from the thicker film produced a slightly larger uncertainty range compared to the thinner 
film. However, RI could be used to identify the components of a mixture that co-elute with poor 
resolution of peaks.  RI has the potential to reduce false positives and decrease the backlog of 
drug analysis requests in forensic laboratories. However, for a universal library, the experimental 
parameters would have to be standardized on the most common columns used in drug analysis 
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 In 2011, over 1.5 million people were arrested for drug abuse (FBI, 2011).  The highest 
arrest rate was for drug abuse violations which involved manufacturing, selling, and possession 
of controlled substances. Requests for drug analysis accounted for nearly half of all requests 
(DNA, toxicology, latent prints, etc.) submitted to forensic laboratories in the United States.  
According the Drug Enforcement Agency (DEA) (2011), marijuana/THC was the most 
frequently identified controlled substance followed by cocaine, methamphetamine, and heroin. 
The detection of amphetamines has nearly doubled and oxycodone has quadrupled in the past ten 
years.  According the a study funded by the National Institute of Justice (NIJ) found that 
laboratories are able to process about 80% of their controlled substances requests (Storm et al., 
2010).  However, there is still an estimated backlog of around 220,000 cases per year.  This 
backlog accounts for nearly half of the total backlog of forensic laboratories. If a technique could 
be used to shorten drug analysis turnaround, then the backlog of cases could be decreased.   
 The use of gas chromatography/mass spectrometry (GC/MS) in forensic drug analysis 
can present problems in possible misidentification of new designer drugs or false positive in 
analytes with nearly identical mass spectra.  GC/MS analysis combines two techniques to 
identify an unknown mixture or sample. The gas chromatograph (GC) serves to separate 
components in the sample via analyte retention to the column retention of the column prior to 
introduction into the mass spectrometer.  GC analysis alone cannot provide definitive 
identification of an analyte, but the retention time still provides useful information.  The 
Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG) defines the GC 
method as a category B analytical technique (SWGDRUG, 2013).  This means that the 
discriminating power of the GC retention time alone is less than that of a category A analytical 
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technique.  SWGDRUG defines the MS as a category A technique, which means that the 
discriminating power of the technique is high.  In contrast, a category C technique, such as color 
tests, has a low discriminatory power because they can only give an idea of what the drug 
structure may contain as it only tests for the presence of particular functional groups. Therefore, 
GC retention time could provide useful information even if not a definitive identification.   
Mass spectrometry can provide identification through the use of spectral matching from a 
library or database such as from the National Institute of Standards and Technology (NIST).  
SWGDRUG also recommended that when a category A analytical technique is used, an 
analytical technique from the other three categories (A, B, or C) should also be used. The 
combination of the GC and MS meets this requirement and thus provides identification of a 
given compound as long as the appropriate reference materials are used.   
 Gas chromatography combines a carrier gas, typically helium or hydrogen, with a 
stationary phase or silica-based column (See Figure 1). The most common injector used in 
forensic application for the gas chromatograph is a split/splitless injector. The components of the 
sample are vaporized in the gas chromatograph injector port and pushed through the column by 
the carrier gas.  The carrier gas is inert and does not play a role in the partitioning process. The 
compound volatizes into the carrier gas in the heated injector port and is then forced through the 
column. The components of a sample are separated based on the relative affinity of the analyte 
for the stationary phase. The interactions between the analyte and stationary phase cause the 
components of the sample to elute from the column at different times, called the retention times.  
The retention times should be reproducible under the same experimental conditions and 
stationary phase but the specificity depends on the detector.  No structural information is 




Figure 1. Diagram of Gas Chromatography 
 
 The most common columns used in forensic science are DB-1 (100% 
dimethylpolysiloxane) and DB-5 (5% phenyl 95% methylpolysiloxane) with different vendors 
using different labeling schemes. DB-1 and DB-5 columns are both considered to be non-polar 
columns. DB-5 columns are slightly more polar compared to DB-1 columns because of the 5% 
phenyl addition to the column.  Analytes in the mixture separate in non-polar columns based on 
their affinity for the phase.  DB-1 columns have a low selectivity which means that analytes are 
separated primarily by their boiling point.  This is advantageous to drug analysis, because it will 
separate a variety of drugs. Amine columns can also used for the analysis of basic drugs.  These 
columns allow for the analysis of basic drugs without having to derivatize them first.  These 
columns are not used as often in forensic laboratories compared to DB-1 and DB-5.   
Capillary columns are used in drug analysis.  The liquid stationary phase is coated on the 
wall of the column. The column diameter, film thickness, and column length should be 
considered when choosing the most efficient column for drug analysis. The diameter of the 
column affects carrier gas flow rate. Generally, columns with a smaller inner diameter will 
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provide a more efficient separation. An increased carrier gas pressure is needed to accommodate 
smaller diameter columns. The length of the column affects the retention time, column 
efficiency, and flow resistance. The film thickness effects the interactions with the analyte(s) in 
the sample. A thicker film provides a higher capacity for the analyte(s) to partition into and thus 
increases the overall retention that is possible. A thicker film would be used for analytes that are 
highly volatile while a thinner film can be more suitable for analytes with a high boiling point 
and molecular weight. The temperature of the column in the oven should also be considered.  
In chromatography, the ideal is a narrow symmetrical peak that is Gaussian in shape. The 
Plate theory is often used to describe column efficiency and the model is derived from the 
distillation theory.  The theoretical plates are measured from the width of the peak in the 
chromatograph. The more plates a column has, the narrower the peaks are, and therefore the 
more efficient the column is.  The van Deemter equation (Eq. 1.1) describes the factors that 
contribute to peak broadening and thus influence the theoretical plate height (H or HETP, height 
equivalent of a theoretical plate).   
                                                     H= A + B/u +Cu                                                      (1.1) 
 The A term is the Eddy diffusion term.  This is defined as the multiple paths an analyte can take 
through the column.  This term is negligible in capillary columns and is ignored, but was 
important in packed columns that dominated early GC instrumentation.  Although packed 
columns are still used in some applications, they are rarely used in forensic analyses. The B term 
is the longitudinal diffusion term.  Analytes have a tendency to diffuse from higher 
concentrations to low dilute concentrations.  The longer the analyte is on the column, the more 
time it has to diffuse and cause the peak to broaden.  At high flow velocities (term u), this term is 
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negligible.  However, when the flow velocity is raised, the C term (resistance to mass transfer) is 
affected.   The C term describes the interactions with between the analyte and the stationary 
phase.  For example, a column with a thicker film thickness will have a higher C term due to 
more binding sites being available.  Often, these terms are plotted to find the maximum column 
efficiency which is met when H (plate height) is small.  
 After the sample elutes from the GC column, it enters the detector where an electrical 
signal is created.  The means of creating this signal depends on the detector.  There are several 
detectors that can be used in combination with the GC.  Two that are commonly used in drug 
analysis are a mass spectrometer (MS or MSD) and a flame ionization detector (FID). This 
detector involves the use of a flame supplied from hydrogen and air.  The analyte is ionized in 
the flame and the resulting ion current is measured by a collection electrode to produce a 
chromatograph. The detector is mass sensitive, and is only responsive to combustible carbon 
compounds.  If a small amount of carbons are present, a small peak will be generated.  The 
technique is highly sensitive and rugged.  This detector is limited in that it will not detect most 
compounds that are not hydrocarbons. Therefore, it does not detect water. A disadvantage to the 
technique is the sample is destroyed in the process of detection.  Due to its robustness, the 
GC/FID is often used as a screening tool in drug analysis. However, since this project focuses on 
mass spectrometry, no further discussion of FID will be presented.  
The main components of a mass spectrometer are displayed in Figure 2. An electron 
ionization source is most commonly used in GC.  In these designs, a filament produces electrons 
that are attracted to an electrode held at 70 electron volts (eV) with the entire detector kept under 
vacuum (on the order of 10
-5
 Torr or 10
-3
 Pa).  As the compounds exit the capillary column, they 
travel past the electrons produced by the filament. The electrons cause ionization and 
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fragmentation. As long as the ionization energy is the same and the MS is performing nominally, 
the fragmentation pattern should be reproducible.  The charged ions that exit the ion source, are 
focused into a beam via lenses, and accelerated into the mass analyzer.  The ionized components 
are attracted toward the mass analyzer, typically a quadrupole design. 
A quadrupole mass analyzer is comprised of four rods that produce an electromagnetic 
field that allow ions with stable trajectories to pass through.  DC currents and radiofrequencies 
are applied to the rods which allow for selected ions to pass through.  The unstable ions are not 
able to pass the length of the rods and will not reach the detector. The detector converts ions to 
electrons and amplifies the electron signal.  When quadrupole voltages are scanned, the detector 
response can be plotted as a function of voltage to produce a mass spectrum.  Since the 
fragments are distinctive of the compound, the fragments allow for identification of the analyte. 
This technique is considered a hard ionization technique because of the extent of fragmentation. 
 
Figure 2. Diagram of ion source and mass analyzer in Mass Spectrometry  
 
 In general, the first step toward identification of a compound that elutes from the GC is 
an evaluation of the mass spectrum searched against an extensive library of references. The 
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library will then generate a list of potential matches along with a measure of similarity between 
the sample spectrum and the library entry.  Forensic laboratories typically utilize a mass spectral 
library published by the National Institute of Standards and Technology (NIST).  Difficulties 
arise when the authentic spectrum is not in the database such as the case with “designer drugs” 
such as the synthetic cannabinoids, cathionones, and so-called “bath salt” compounds. Designer 
drugs are often derivatives of illegal drugs that are created to obtain similar effects of the illicit 
substance without the legal implications. Bath salts are said to have similar effects to the use of 
amphetamine and cocaine (DEA 2012).  However, they have caused hallucinogenic effects, 
paranoia, a heart attack, and liver failure. Because so many of the compounds in these groups 
share similar structures, the mass spectra are often similar.  This problem, combined with the 
lack of standards available for designer drugs, significantly decreases the value of the mass 
spectrum alone for making an identification. 
  For example, cathinones or “bath salts” are often amphetamine derivatives in which the 
molecular ion is barely or not present using MS.  A study was done on bath salt derivatives and 
found two common derivatives (cathinone, methcathinone) had very similar retention times 
using GC/MS (3.69 and 3.86 minutes respectively) (Locos and Reynolds, 2012).  The base peak 
or peak with the greatest intensity, of cathinone is m/z 44 which is the same base peak of 
amphetamine.  A derivative, methcathinone has a base peak of m/z 58 which is the same base 
peak of methamphetamine (NIST Chemistry WebBook, 2013). If these compounds are searched 
in the NIST database, a false positive identification to amphetamine or methamphetamine could 
be produced. RI could differentiate these cathinone derivatives which could reduce false positive 
identifications especially since reference materials may not be available for all the derivatives of 
cathinone in the NIST database.   
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 While GC/MS is used in most laboratories in the United States, the technique does have 
some limitations in drug analysis.  One main limitation of only using mass spectra libraries is 
that the spectra cannot differentiate between all analytes (Babushok et al. 2007).  This can lead to 
a possible false identification or a possible false positive of a drug sample. For example, 
phentermine and methamphetamine produce a nearly identical spectra.  While both are 
controlled substances, phentermine is a Schedule IV drug while methamphetamine is a Schedule 
III to II drug.  Schedule III to II drugs have a higher dependency while schedule IV drugs have a 
lower potential for abuse.  The difference in penalty can range from only getting a fine for 
having a schedule IV drug to spending years in prison for having a Schedule III to II drug.  Thus, 
false positives can have enormous consequences.  This is one reason why retention indices still 
play an important role in seized drug analysis.  As the overflow of designer drugs continues and 
more and more compounds with similar or identical spectra enter the forensic system, retention 
indices could become vital for screening purposes. 
 Retention index (RI) was developed in 1958 by Kovats (Zellner et al., 2008).  Relative 
retention times are used in place of absolute retention times for the calculation of retention index.   
A relative retention time describes the relative position of the unknown retention time between 
two hydrocarbon’s retention times. The unknown is described from its location between two 
hydrocarbons, making it less subject to experimental changes compared to the raw retention time 




Figure 3. Diagram of hydrocarbon ladder and target analyte 
 
 Kovats developed the method to improve peak identification. However, he learned that 
the larger the span of retention time between the reference and sample peaks, the less accurate 
the identification was based on retention index alone.   Kovats used a homologous series of 
alkanes now known as a hydrocarbon ladder.  Under isothermal conditions, the retention times of 
the alkanes increased exponentially (See Figure 4). Kovats determined that that a semi-
logarithmic relationship between the adjusted retention times of the ladder and their carbon 
numbers existed (See Figure 5).  It was defined that the carbon number of the alkane multiplied 





Figure 4.  Hydrocarbon ladder under isothermal conditions. A two minute solvent delay was 
used.   
 
 
Figure 5. Plot of Carbon number plotted against retention time at 150ºC for the hydrocarbon 
ladder  
 
The calculation is shown below for Kovats retention index (I) calculated from isothermal 
conditions (Eq. 1.2). 
                                                   Ix =  100n +  100[log(tx’)-log (tn’)]                                      (1.2) 























Carbon Number C8-C20 
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Where n equals the number of C atoms of the preceding hydrocarbon, tn is the preceding 
hydrocarbon adjusted retention time, tn+1 is the following hydrocarbon adjusted retention time 
and tx is the adjusted retention time of the analyte.  The advantage to Kovats RI method is that Ix 
is independent of most experimental conditions with the exception of the stationary phase of the 
column and the isothermal temperature of the column. 
With the development and improvement of temperature programming to the GC, a 
modified version of the equation developed by Kovats was required, known as linear retention 
indices (LRI).  It was shown that when a temperature program was applied, the ladder eluted in a 
linear mode (See Figure 6). 
 
Figure 6. Plot of Carbon number against average retention time of 24 replicates of hydrocarbon 
ladder. This example was obtained from a Perkin Elmer GC, described in detail the “Methods” 
























































































































































Carbon Number (C9-C33) 
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Since the retention times did not increase exponentially, the logarithmic scale could not be used 
in this equation.  The modification was developed by Van den Dool and Kratz (Babushok et al. 
2007) and shown below (Eq. 1.3). 
                                                       Ix =  100n + 100 (tx-tn)                                                        (1.3) 
                                                                                (tn+1-tn)  
 
where tn is the preceding hydrocarbon retention time, tn+1 is the following hydrocarbon retention 
time and tx is the retention time of the analyte.      
The most commonly used indices are Kovats and Linear RI. Other retention indices exist 
such as Lee indices, which use polyaromatic hydrocarbon standards. The Lee indices also have 
different calculations for isothermal conditions and temperature programming conditions.   Since 
most unknown drug samples require the use of temperature programming and it is now more 
common, linear retention indices were the focus of this work.  Linear retention indices are 
dependent on the stationary phase of the column and the temperature program but when used 
under the same experimental conditions are reproducible  
Babushok et al. (2007) provided an in depth discussion of the development of a database 
of retention indices from NIST.  The authors examined how the database was constructed as well 
as the type of information that is provided.  The database was constructed mostly through peer 
reviewed publications from 1956-2005.  The indices that are reported in the database are Kovats, 
Linear, and Lee.  Most of the data present in the database is calculated from Linear indices 
followed by Kovats indices.  Only a small portion of the data is calculated using the isothermal 
or non-isothermal Lee indices.  The columns described in the database are from non-polar or 
polar columns.  A large portion of the data on non-polar columns was performed on a 100% 
dimethylpolysiloxane stationary phase which is seen in DB-1 columns, HP-1, and SE-30 
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columns.  The second largest portion of data on non-polar columns were performed on methyl 
silicone, 5% phenyl groups stationary phase which are seen on DB-5 and HP-5 columns.   
With the large time span of the data gathered, quality control measures were developed to 
try to eliminate erroneous and suspicious data.  Some of the problems with assigning the quality 
control measures were the lack of replicates.  About 53% of the compounds only had one value 
reported so the uncertainty associated with that value is unknown. A small number (2.4%) of 
compounds had 48 or more replicates.  The values were only compared if the same experimental 
conditions were present.  The data with sufficient replicates were compared to an estimated value 
of RI.  A value was ruled suspicious if the experimental procedure was not clearly defined, if the 
source stated problems during the experimental procedure, or if the results of RI contained a 
large variability with other sources for the same compound.  The estimation of RI involved a 
group additivity scheme used from Stein et al. (2007).  If a large variability was present, the 
conditions in which RI was calculated were examined further and eventually characterized into 
the quality control definitions of acceptable data, suspicious data, or data very likely in error.  
Some possible reasons for the large variations for some of the values that were reported could be 
explained by improperly reporting RI, applying the wrong calculation of RI which could lead to 
a misidentification of the compound that has been assigned the RI value, and possible different 
temperature programs used.  Only values deemed acceptable are seen in the NIST database for 
RI.  The database is available from NIST Chemistry WebBook and was released in June 2005.    
 Another study by Toth and Praszna (1998) examined reproducibility of RI on DB-1 
columns.  The RI studied was calculated using Linear RI.  The authors found better repeatability 
when they applied a correction factor on the hydrocarbon ladder to normalize the ladder. 
Although, for the correction factor to be applied, the unknown sample has to contain one alkane 
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from the hydrocarbon ladder.  The unknown sample and the ladder have to have been injected 
separately as well.   
 A study by Lebron-Aquilar et al.(2002) showed that Kovats index can generate a 
repeatability of RI to one-tenth of a retention index unit (riu).  This calculation involved a non-
linear equation and can only be used under isothermal conditions. Specific experimental 
conditions were required to achieve accuracy to one-tenth of a riu.  At least five runs of the 
sample, retention times measured at 0.1 second or 0.001 min, and the non-linear regression 
formula cited in the paper had to be applied.  Given that the consensus values for RI are cited to 
whole numbers, the ability to report to one decimal place is a significant improvement; the 
tradeoff lies in the experimental constraints.     
 Zhang et al. (2011) studied the experimental effects of RI to use a software program 
called iMatch that uses spectral matching while also using separation information.  The authors 
used information presented in the NIST 2008 RI database to look at several experimental 
parameters that could influence RI and grouped them based on their impact. The authors were 
able to group some of the experimental parameters together to ultimately create distribution 
functions from the grouped RI data. The authors applied the distribution functions into a 
software program called iMatch to try and eliminate false positives in spectral matching.   The 
most significant findings of their study were that column class, type, and data type do have an 
impact on RI.   
Research currently on RI has been in developing an accurate method for the prediction or 
estimation of RI values.  There is also much interest to having a tool that could increase 
repeatability for RI.  This would allow for a larger amount of analytes to have an estimated 
retention index.  This could ultimately lead to a database with more analytes which could lead to 
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identifying unknown samples such as drugs.  Currently these values are reported in the database, 
and often it is seen that the estimated values vary from the experimental values of RI. More 
research needs to be done in this area before assigning retention indices to all compounds 
without using experimental values. 
 The Scientific Working Group for Seized Drugs and Analysis (SWGDRUG) proposed 
the use of RI to aid in identification on newer designer drugs for which reference materials are 
not yet available in July 2011 (Placke, July 2011).  The goal was to add RI information to the 
current SWGDRUG MS library and drug monographs (http://www.swgdrug.org/monographs, 
last accessed April 2013).  Data was complied on thirty drug samples to measure the variability 
of the data between laboratories (Mead, January 2012). Under the same GC and MS conditions, 
using a HP-1 column, each RI data value was within 2% of the same data value at each of the 
three laboratories showing a good inter-laboratory reproducibility (See Table 1).  As of this 
writing, these RI values were being added to the SWGDRUG MS library as of 2013.   
Table 1. RI values of 9 illicit drugs over four stationary phases from SWGDRUG.   
Standard Name  
DB-1  12 x 0.20 
x 0.33 
ZB-50 15 x 
0.25 x 0.25 
ZB-5 15 x 
0.25 x 0.25 
DB-1 25 x 
0.20 x 0.33 
Methamphetamine 1174 1372 1201 1183 
Amphetamine 1116 1335 1145 1121 
Phentermine 1156 1357 1179 1164 
Pentobarbital 1729 2121 1772 1730 
Butabarbital 1660 2055 1694 1655 
Phenobarbital 1951 2540 2016 1960 
Heroin 2658 3410 2744 2668 
Oxycodone 2562 3330 2649 2582 




 According to a recent report on forensic science, the Proceedings of the National 
Academy of Sciences (NAS) (came out in February ’09, copyright July 2009), any laboratory 
results should be reported with a level of confidence or uncertainty.  Some laboratories meet this 
requirement, but many do not have procedures in place to do this. Presently, RI values are 
reported as whole numbers, with no associated ranges or uncertainty values.  To meet this spirit 
of the NAS report, uncertainty values should be investigated for RI to increase the level of 
confidence in reporting RI.    
Estimated values of RI are shown in the NIST MS Search 2.0 database 
(www.swgdrug.org) as well as published RI values. As an example, consider methamphetamine 
which has an estimated value of 1226 index units using this database.  Two published sources list 
lower values of 1175 iu (Christ et al., 1988) and 1150 iu (Oyama et al., 1987).  If a forensic 
laboratory determines an RI value of 1160 for a peak thought to be methamphetamine, this data 
would likely not be comparable to the NIST database, nor to the published values unless 
uncertainties are provided for all four measured RIs.  Also, the estimated RI value is much higher 
than the two experimental values, a discrepancy that was discussed earlier.  Clearly, for LRI to 
be of value across forensic laboratories, uncertainty ranges will be essential, particularly for 
structurally similar designer drugs that are expected to have similar mass spectra as well as 
similar retention times.  In these cases, small differences in retention time could be important.  
This project was geared toward providing uncertainty estimations and a statistical investigation 







Nine drug standards were examined in this study, falling under the groups of stimulants 
(See Table 2), depressants (See Table 3), and narcotics (See Table 4). An attempt was made to 
include acidic and basic drugs with a range of pKa values.  
 Methamphetamine is also known as desoxyn, d-desoxyephedrine, crystal meth, ICE, 
crank, or speed (DEA 2012). In large doses, methamphetamine may have a hallucinogenic effect.   
Prescription names for amphetamine are Adderall, Obetrol, and Dexedrine.  This is commonly 
used in the treatment of attention deficit hyperactivity disorder (ADHD).  Phentermine has less 








Table 2. Drug table of stimulants 
Drug Structure Formula MW pKa Schedule 
Methamphetamine 
 
C10H15N 149.2 10.1 II 
Amphetamine 
 
C9H13N 135.2 10.1 II 
Phentermine 
 
C10H15N 149.2 10.1 IV 




Barbiturates are drugs that are used to depress the central nervous system and have fallen 
out of popularity.  They are used for insomnia, to relieve muscle spasms, and to calm.  These 
drugs develop tolerance quickly and are classified as ultrashort, short, immediate, and long-
acting (Levin 2010).  
 Pentobarbital is a short acting drug compared to the other two drugs and also goes by the 
trade name Nembutal.  Butabarbital is commonly used to treat migraines and insomnia since it is 
short acting. Some common names are Sonabarb, and Soneryl (DEA 2012).   Phenobarbital is a 
longer acting drug and commonly used to treat seizures. Some prescription names for this drug 
are Aparoxal, Comizial, and Solfoton. Although these drugs are not subject to abuse to the extent 
they were twenty years ago, they were included in this study to represent acidic drugs 
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Table 3. Drug table of barbitals 
Drug Structure Formula MW pKa Schedule 
 Pentobarbital 
 
C11H18N2O3 226.3 8.0 (20 º) II 
Butabarbital 
 
C10H16N2O3 212.3 8.0 (25º) III 
Phenobarbital 
 
C12H12N2O3 232.2 7.4 (25º) 
IV 
Referenced from: Clarke’s Analysis of Drugs and Poisons, 2004 
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The narcotics (opiate) contained three separate drugs standards of heroin, oxycodone, and 
codeine.  Opiates affect the central nervous system, dull senses, and relieve pain.  Some common 
uses for opiates include analgesia, trauma, and pain management. 
 Heroin is also known as diacetylmorphine and diamorphine (DEA 2012). Oxycodone is 
typically prescribed for pain management.   Some prescription names are OxyContin, Percocet, 
Endocet, Roxicodone, and Roxicet.  Codeine can typically be prescribed for injuries and 
musculoskeletal issues. Some common names include morphine methyl ester and methyl 



















Table 4. Drug table of depressants 
Drug Structure Formula MW pKa Schedule 
Heroin 
 
C21H25NO5 369.4 7.6 (23º) I 
Oxycodone 
 
C18H21NO4 315.4 8.9 (20º) II 
Codeine 
 
C18H21NO3 317.4 8.2 (20º) II 





 The first objective was to determine the repeatability (same instrument, same conditions) 
and reproducibility (between two gas chromatographs of different manufacturer under same 
temperature programming) of the nine drug standards.  Nine drug standards will be used to test 
variability of linear retention indices between two columns of same stationary phase made by 
different manufacturers and test the reproducibility of RI between the two instruments. The 
column used was a 5% phenyl 95% methylpolysiloxane stationary phase.   
The second objective was to estimate the uncertainty of the LRI of the nine drug 
standards.  A traditional hydrocarbon ladder was used for the columns to generate uncertainty 
values for each drug so that the variability of LRI between columns could be examined. 
Linear retention indices were applied using the retention time of the apex (top) of the 
peaks from the proceeding and following hydrocarbons. The same stationary phase, temperature 
program and carrier gas were used on two different gas chromatograph mass spectrometers.  
Analyses were performed on a Shimadzu and PerkinElmer GCs.    
Significance to Forensic Science 
 
 Retention indices are used is forensic laboratories today for screening of compounds and 
as an additional aid for the identification of compounds. LRI can differentiate between two 
analytes (such as LSD and LAMPA or methamphetamine and phentermine), that have give 
similar spectra.  This could be useful when analyzing designer drugs, specifically synthetic 
cannabinoids and bath salts. 
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  The inter-laboratory values of LRI need to be examined to assess the variability and 
reproducibility of LRI.  Many limitations or concerns that need to be addressed deal with the 
standardization of the experimental parameters that influence the retention times used to 
calculate LRI.  Since many laboratories use LRI for the screening of drugs, it is essential to 
define quantitatively repeatability and reproducibility values to determine if inter-laboratory use 
is even possible. If a reliable database can be developed, with a known confidence interval, the 
reliability in the approach of LRI would become another tool in the forensic community for 






Sampling was performed on two GC/MS instruments.  
Table 5. Parameters of instruments 
 
Method 1 Method 2 Method 3 
Instrument 
Shimadzu GC-2010 
with a QP2010S Mass 
Spectrometer 
PerkinElmer Clarus 




500 GC with a Clarus 
SQ8T Mass 
Spectrometer 
Column Type Rxi-5SiMS w/ Integra-
Guard 
ZB-5 MSi ZB-5 MSi 
Column Length 30 m x 0.25mm x 0.50 
um 
30 m x 0.25 mm x 
0.25 um 
30 m x 0.25 mm x 
0.25 um 









Temperature Program 80ºC (1 min) @ 10 
ºC/min to 280ºC (10 
minutes) 
80ºC (1 min) @ 10 
ºC/min to 280ºC (10 
minutes) 
80ºC (1 min) @ 10 
ºC/min to 280ºC (10 
minutes) 
Split Ratio 10: 1 10: 1 10: 1 
Injection Temperature 280 ºC 250 ºC 280 ºC 
Ion Source Temperature 260 ºC 260 ºC 260 ºC 
Interface Temperature 270 ºC 280 ºC 270 ºC 
Column Flow 1.00 mL/min 1.00 mL/min 1.00 mL/min 
Carrier Gas Helium Helium Helium 







 The hydrocarbon ladder used was from Supelco
®
 (Bellefonte, PA).  The standard alkane 
kit included C7 to C40 saturated alkanes in a concentration of 1000 ppm. The ladder was diluted 
to a concentration of 100 ppm using hexane.  The drugs used were methamphetamine, 
amphetamine, phentermine, heroin, oxycodone, codeine, pentobarbital, butabarbital, and 
phenobarbital.  Each drug standard was diluted with methanol.   Pentobarbital and butabarbital 
standards were purchased from Cerillant
®
 (Round Rock, TX).  Phenobarbital, D-amphetamine, 
phentermine, codeine, and Oxycodone hydrochloride were from Sigma Aldrich
®
 (St.Louis, MO) 
in a powder form.  Methamphetamine was from Restek
®
 (Bellefonte, PA).   
Experimental conditions 
 
  The test conditions from Supleco
®
 were used first to make sure all the alkanes in the mix 
were detectable. The column used was Rxi-5SiMS w/ Integra-Guard by Restek
®
.  Hexane was 
used to dilute the ladder from 1000 ppm to 100 ppm. The temperature programming used was 35 
ºC (2 min) to 250 ºC @ 10 ºC/min to 320ºC (20 min) @ 20 ºC/min. with a split ratio of 25:1.   
The ladder was diluted to concentrations of 10 ppm and 100 ppm to see which concentration was 
optimal across the ladders.  The solvent delay was set at 10 minutes and C11-C40 compounds 
were detected at a concentration of 100 ppm which gave the most symmetrical and Gaussian 
shaped peaks.  The run was repeated 5 times.  The chromatographs and mass spectra from the 
Shimadzu GC are shown in black, while the chromatographs and mass spectra from the 
PerkinElmer GC are shown in red.  This is how they are displayed in the software of each GC.   
 A second method was developed to have a shorter total run time of 30 minutes. This 
method was used to develop a shorter analysis time and lower temperature of the oven.   The 
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column used was Rxi-5Si MS w/ Integra-Guard.  This method was 80 ºC (1 min) @ 10ºC /min to 
280 ºC (10 minutes), with a split of 10:1.  Using this method, peaks were observed for C9-C33 
with a solvent delay time of 2.51 minutes.  This range included the elution times of all the drugs 
studied.  A solvent delay of 3 minutes was used for the duration of the study due to seeing 
solvent at a delay of 2.51 minutes.   The equilibration time for the Shimadzu GC was 1 minute 
while the PerkinElmer was 2 minutes.  Once the oven temperature reaches the starting oven 
temperature, it holds the temperature for the equilibration time to reach thermal equilibrium.  
Results in this study did not suggest that this difference was a factor. 
 The mass spectrum was used to identify the alkanes.  Molecular ions were used until 
C24.  After C24, the molecular ion fell outside of the scan range of 30-350 amu. Alkanes C7 and 
C8 were not observed and likely eluted during the solvent delay.  This did not present any 
problems for calculating RI for the drugs studied here.  To determine intra-day variability and 
inter-day variability, data was collected on five separate days.  Each standard was analyzed in 
triplicates.  The ladder was run three times prior to the drug standards each of the five days. The 
nine drug standards all were confirmed using the NIST database for mass spectrometry. 
Calculation of LRI 
 
 LRI was calculated from the equation below.  This is the same equation as formula (Eq. 
1.3).  A macro was created for SWGDRUG from the Oklahoma State Police using this equation.  





                                                 Ix =  100n +  100 (tx-tn)                                               (1.3) 
                                                                                    (tn+1-tn)  
                
   tn = The retention time of the unknown 
   tx = The retention time of the preceding hydrocarbon 
   tn+1= The retention time of the following hydrocarbon 
   n= The number of carbons of preceding hydrocarbon 
 
For example, a methamphetamine sample eluted at 8.50 minutes.  The compound falls between 
C11 and C12 with a retention time of 7.03 and 8.50 min respectively.  The LRI of 
methamphetamine would be: 
LRI= [(8.40-7.03)/(8.50-7.03)*100] + [11*100] 
LRI= (1.37/1.47)*100 + 982 
LRI= 93.20+ 1100 
LRI= 1193 
The LRI value is reported to a whole number by convention. 
 Currently, the determination of uncertainty values for quantitative forensic data is a 
significant concern, as noted earlier. While it is recognized that detailed approaches such as 
uncertainty budgets can and are used in the context of seized drug analysis, this approach was 
not taken here.  Rather, the uncertainty (i.e., the range in which a true value is expected to be 
found with a given confidence) is estimated using a 95% confidence interval.  For initial study 





Results and Discussion 
Hydrocarbon ladder-Shimadzu GC  
 
 The temperature program provided by Supleco
®
 was used to ensure all alkanes were 
present. Alkanes C11-C40  were present on the Shimadzu GC using a solvent delay of 10 
minutes (See Figure 7). This ladder was run in five replicates to measure repeatability.  This 
temperature program was only used to ensure the alkane ladder was complete. The %RSD for all 
peaks were less than 0.01 or 1%. The temperature program was not suitable for the rest of the 
data collection to do the high temperature of 320ºC for 20 minutes and a total run time of 47 
minutes.     
 
Figure 7. Hydrocarbon ladder C11-C40 on the Shimadzu GC.  The elevated baseline at the end 
is column bleed. 
 
 The molecular ion of the first peak was used to determine the first alkane that eluted (See 
Figure 8).  From the m/z charge of 156, it was determined the first alkane shown was C11. 




Figure 8. Mass spectrum of C11 on the Shimadzu GC.  Molecular ion of 156 m/z shown  
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 One consideration in calculating linear retention indices is the significant figures reported 
for the retention time. The retention times for the Shimadzu GC were rounded to two decimal 
places even though the software provided to three decimal places.  This was due to the 
PerkinElmer GC reporting retention times to two decimal places.  All the linear retention indices 
were eventually reported as whole number, but in order to have unity among rounding for each 
instrument, two decimals places were used for the retention times of each sample (prior to 
rounding to the whole number for the calculated linear retention index).    
 Five replicates of the ladder were run on the same day to determine the intra-variability 
using the temperature program supplied by Supleco
®
.  The %RSD of alkanes C11-C36 is smaller 
compared to the alkanes C37-C40 which are slightly larger (See Table 6). These alkanes retain in 
the column longer and have more time to interact with the stationary phase where cause broader 
peaks, which accounts for the slightly larger %RSD.   
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Table 6.Intra-day variability of retention times of 5 replicates of hydrocarbon ladder.  Temperature Program supplied from Supleco
®
.   
 
C11 C12 C13 C14 C15 C16 C17 C18 C19 C20 C21 C22 C23 C24 C25 
Average 11.45 13.03 14.51 15.90 17.21 18.44 19.61 20.72 21.78 22.79 23.74 24.56 25.26 25.86 26.40 
SD 0.002 0.001 0.001 0.002 0.002 0.008 0.002 0.001 0.002 0.001 0.001 0.002 0.002 0.001 0.002 
%RSD 0.01 0.01 0.01 0.01 0.01 0.04 0.008 0.007 0.007 0.004 0.006 0.006 0.008 0.004 0.006 
 
 C26 C27 C28 C29 C30 C31 C32 C33 C34 C35 C36 C37 C38 C39 C40 
Average 26.89 27.35 27.84 28.37 28.97 29.65 30.44 31.37 32.46 33.76 35.31 37.16 39.37 42.04 45.25 
SD 0.001 0.001 0.001 0.002 0.002 0.002 0.003 0.002 0.005 0.004 0.003 0.006 0.01 0.009 0.04 







The hydrocarbon ladder was run in replicate to determine the intra-day variability using 
the temperature program from Method 1 on the Shimadzu GC (See Figure 9).  C8-C29 eluted on 
the Shimadzu GC with a solvent delay of 3 minutes.    
 
Figure 9. Hydrocarbon ladder C8-C29 on the Shimadzu GC.  Temperature program used in 
Method 1.  
 
The molecular ion of the first peak was used to determine the first alkane that eluted (See Figure 
10).  From the m/z of 114, it was determined the first alkane shown was C8. The molecular ion 
was seen until C24 at a m/z ratio of 338 (See Figure 11). The MS program was set to scan from 















Ten replicates of the ladder were run on the same day to determine the intra-day variability using the temperature program in 
Method 1 on the Shimadzu GC (See Table 7). The highest %RSD of 0.04 was observed at C9.      
Table 7.  Intra-day variability of retention times of 10 replicates of the hydrocarbon ladder  
 
C8 C9 C10 C11 C12 C13 C14 C15 C16 C17 C18 
Average 3.22 4.26 5.57 7.01 8.48 9.91 11.28 12.58 13.82 14.99 16.10 
SD 0.001 0.002 0.002 0.002 0.002 0.001 0.002 0.001 0.001 0.002 0.001 




 C19 C20 C21 C22 C23 C24 C25 C26 C27 C28 C29 
Average 17.16 18.17 19.13 20.05 20.94 21.84 22.88 24.09 25.55 27.33 29.53 
SD 0.001 0.001 0.001 0.002 0.001 0.001 0.002 0.003 0.004 0.004 0.004 




 The inter-day variability of the ladder was examined within the Shimadzu GC (See Table 
8). The first day of sampling was compared to the last day of sampling, which corresponded to 
an elapsed time of one month.  A one-way ANOVA was calculated for the inter-day variability 
(See Table 9).  The F value is higher than the Fcritical value and the p-value was less than 0.05, 
therefore the null hypothesis was rejected (stating that the means were the same on both days). 
The alternate hypothesis was accepted, the means are not the same between day 1 and day 5. 
This is a result of the very tight distributions associated with a specific peak retention time on a 
single day.     
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Table 8. Inter-day variability of hydrocarbon ladder compared to day 1 and day 5 of sampling 
 
C8 C9 C10 C11 C12 C13 C14 C15 C16 C17 C18 
Day 1 3.24 4.28 5.59 7.03 8.50 9.93 11.30 12.61 13.84 15.01 16.12 
Day 1 3.24 4.29 5.59 7.04 8.50 9.93 11.31 12.61 13.84 15.01 16.12 
Day 1 3.24 4.29 5.59 7.04 8.50 9.93 11.31 12.61 13.84 15.01 16.12 
Day 5 3.23 4.27 5.57 7.01 8.48 9.91 11.28 12.58 13.82 14.99 16.10 
Day 5 3.23 4.27 5.57 7.02 8.41 9.91 11.28 12.58 13.82 14.99 16.10 
Day 5 3.23 4.27 5.57 7.02 8.48 9.91 11.28 12.58 13.82 14.99 16.10 
            
Average 3.24 4.28 5.58 7.03 8.49 9.92 11.29 12.60 13.83 15.00 16.11 
SD 0.006 0.009 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
%RSD 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.09 0.08 0.08 
 
 C19 C20 C21 C22 C23 C24 C25 C26 C27 C28 C29 
Day 1 17.18 18.19 19.15 20.07 20.96 21.87 22.91 24.13 25.59 27.38 25.59 
Day 1 17.18 18.19 19.15 20.07 20.96 21.87 22.91 24.12 25.59 27.38 29.59 
Day 1 17.18 18.19 19.15 20.08 20.96 21.86 22.90 24.12 25.59 27.37 29.58 
Day 5 17.16 18.17 19.13 20.05 20.93 21.84 22.87 24.09 25.55 27.32 29.52 
Day 5 17.16 18.17 19.13 20.05 20.93 21.84 22.87 24.09 25.54 27.33 29.52 
Day 5 17.16 18.17 19.13 20.05 20.93 21.84 22.87 24.09 25.55 27.33 29.52 
    
        
Average 17.17 18.18 19.14 20.06 20.94 21.85 22.89 24.10 25.57 27.35 29.55 
SD 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.03 0.04 
%RSD 0.07 0.07 0.06 0.06 0.06 0.07 0.07 0.09 0.09 0.1 0.1 
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SS df MS F P-value F crit 
Between 
Groups 




   1.65 
Within 
Groups 
0.029 110 0.00027 
   
       
Total 7382.60 131 




Hydrocarbon ladder- PerkinElmer GC 
 
 Alkanes C9-C33 eluted on the PerkinElmer GC using a solvent delay of with a solvent 
delay of 2.5 minutes (See Figure 12). This ladder was run in replicates in 24 replicates to ensure 
repeatability. The temperature program used can be seen in Method 2.  
 
Figure 12. Hydrocarbon ladder C9-C33 on the PerkinElmer GC.   
 
 The molecular ion of the first peak was used to determine the first alkane that eluted (See 
Figure 13). From the m/z charge of 128, it was determined the first alkane shown was C10. The 
molecular ion was seen until C24 at a m/z ratio of 338 (See Figure 14). 
 
,  23-Jan-2013 + 13:26:13alkane standard 100ppm L3








































Figure 14. Mass spectrum of C24 on the PerkinElmer GC.  Molecular ion of 338 m/z is shown (in this spectra, the m/z 338 is very 
small, but present.) 
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The molecular ion of the first peak was used to determine the first alkane that eluted with a 
solvent delay of 3 minutes. From the m/z charge of 128, it was determined the first alkane shown 
was C10. The molecular ion was seen until C24 at a m/z ratio of 338 (See Figure 14). 
 Since the Shimadzu GC had a solvent delay of 3 minutes, the PerkinElmer GC was 
changed to a solvent delay of 3 minutes.  Alkanes C10-C33 eluted on the PerkinElmer GC using 
a solvent delay of 3minutes (See Figure 15). All of the drug standards fell within this range; 
therefore this solvent delay was did not influence the linear retention index calculations.  This 
ladder was run in replicates of ten to ensure repeatability. The temperature program used can be 




Figure 15. Hydrocarbon ladder C10-C33 on the PerkinElmer GC.  Temperature program used in 
Method 2. 
The molecular ion of the first peak was used to determine the first alkane that eluted (See Figure 
16) with a solvent delay of 3 minutes. From the m/z charge of 142, it was determined the first 
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Figure 17. Mass spectrum of C24 on the PerkinElmer GC.  Used Molecular ion of 338 m/z is shown (in this spectra, the m/z 338 is 
very small, but present.) 
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 Twenty-four replicates of the ladder were run on the same day to determine the intra-variability using the temperature program 
in Method 1 (See Table 10).   The largest %RSD was seen at C9 at a value of 0.306. 
 
Table 10. Intra-day variability of retention times of 24 replicates of hydrocarbon ladder using Method 2 parameters.  
 C9 C10 C11 C12 C13 C14 C15 C16 C17 C18 C19 C20 C21 
Average 2.67 3.69 4.93 6.26 7.61 8.92 10.18 11.38 12.53 13.62 14.65 15.65 16.60 
SD 0.008 0.009 0.009 0.008 0.008 0.006 0.006 0.006 0.005 0.005 0.01 0.008 0.006 
%RSD 0.3 0.2 0.2 0.1 0.1 0.07 0.06 0.05 0.04 0.04 0.07 0.05 0.03 
 
 C23 C22 C24 C25 C26 C27 C28 C29 C30 C31 C22 C23 
Average 18.38 17.51 19.22 20.03 20.80 21.58 22.49 23.55 24.84 26.39 28.30 30.67 
SD 0.005 0.005 0.005 0.005 0.008 0.008 0.007 0.008 0.03 0.01 0.01 0.01 




 The inter-day variability of the ladder was examined within the PerkinElmer GC (See 
Table 11). The first day of sampling was compared to the last day of sampling.  The time in 
between these two days of sampling is approximately one month.  A one-way ANOVA was 
calculated for the inter-day variability between day 1 and day 5 of sampling (See Table 12).  The 
F value is more than the Fcritical value and the p-value is less than 0.05, indicating that the null 




Table 11. Inter-day variability of hydrocarbon ladder compared to day 1 and day 5 of sampling on the PerkinElmer GC 
 
C10 C11 C12 C13 C14 C15 C16 C17 C18 C19 C20 C21 
Day 1 3.62 4.85 6.17 7.52 8.83 10.09 11.28 12.42 13.51 14.55 15.54 16.49 
Day 1 3.62 4.84 6.17 7.52 8.83 10.08 11.28 12.42 13.51 14.55 15.54 16.48 
Day1 3.62 4.85 6.18 7.53 8.83 10.09 11.29 12.43 13.51 14.55 15.54 16.49 
Day 5 3.61 4.84 6.17 7.52 8.82 10.08 11.28 12.42 13.5 14.54 15.54 16.48 
Day 5 3.62 4.85 6.17 7.52 8.83 10.08 11.28 12.42 13.51 14.55 15.54 16.49 
Day 5 3.62 4.85 6.18 7.52 8.83 10.09 11.28 12.42 13.51 14.55 15.54 16.49 
             
Average 3.62 4.85 6.17 7.52 8.83 10.09 11.28 12.42 13.51 14.55 15.54 16.49 
SD 0.00 0.01 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.01 
%RSD 0.1 0.1 0.08 0.05 0.05 0.05 0.04 0.03 0.03 0.03 0.00 0.03 
 
 
 C22 C23 C24 C25 C26 C27 C28 C29 C30 C31 C32 C33 
Day 1 17.40 18.27 19.11 19.91 20.69 21.46 22.34 23.38 24.63 26.15 28.01 30.31 
Day 1 17.39 18.26 19.10 19.91 20.69 21.46 22.34 23.38 24.62 26.15 28.00 30.30 
Day1 17.40 18.27 19.11 19.92 20.69 21.46 22.34 23.38 24.63 26.14 28.01 30.30 
Day 5 17.39 18.26 19.10 19.91 20.68 21.45 22.33 23.37 24.62 26.14 28.00 30.30 
Day 5 17.39 18.26 19.10 19.91 20.69 21.45 22.34 23.37 24.62 26.14 28.00 30.30 
Day 5 17.39 18.27 19.10 19.91 20.69 21.46 22.34 23.37 24.62 26.14 28.00 30.31 
             
Average 17.39 18.27 19.10 19.91 20.69 21.46 22.34 23.38 24.62 26.14 28.00 30.30 
SD 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.01 0.01 0.01 0.01 0.01 
%RSD 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 
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SS df MS F P-value F crit 
Between 
Groups 
7644.98 23 332.39 1.52 x 10
7
 0 1.62 
Within 
Groups 
0.0026 120 2.18 x 10
-05
 
   
       
Total 7644.99 143 




Hydrocarbon ladder-PerkinElmer GC (modified temperature program from Method 3) 
 
 Since the experimental conditions were not identical in Method 1 and Method 2 between 
the two instruments, the ladder and drug standards were run again using the conditions in 
Method 3.  The experimental parameters were the same and alkanes C10-C33 eluted (See Figure 
18).  The peaks were identified using the m/z ratio of each peak.  It was determined the first peak 
was C10 (See Figure 19) and the last alkane shown was for C24 by their m/z ratio (See Figure 
20).  This corresponds to the ladder run with the temperature program 6 for the PerkinElmer.   
 
Figure 18. Hydrocarbon ladder C10-C33 on the PerkinElmer GC.  Temperature program used in 
Method 3. 
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Figure 20. Mass spectrum of C24 on the PerkinElmer GC.  Used Molecular ion of 338 m/z to identify C24. (in this spectra, the m/z 
338 is very small, but present.) 
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Three replicates of the ladder were run on the same day to determine the intra-variability 
using the temperature program in Method 3 (See Table 13).  The parameters that were changed 
were the injection port temperature and the interface temperature to be consistent with the 
Shimadzu GC/MS parameters from Method 1. 
A hypothesis test (student’s t-test) was applied for comparison between the 15 replicates 
of the ladder with the temperature program from Method 2 to the three replicates from the 
modified temperature program from Method 3.  Since the data is unbalanced, ANOVA could not 
be applied. For the student’s t-test, if the t table value was higher than 5% (marked in bold- See 
Table 14), the null hypothesis was rejected.  Only the values that had some deviation to the mean 
could be compared (alkanes that did not have any deviation are marked “–“).  Three alkanes 
(C14, C22, and C24) had a higher t table value of 0.05 these values cannot be combined with the 
other data set.  However, these three alkanes were not used to calculate the LRI of any of the 9 
drugs, they did not influence the calculation of LRI.   
A paired t-test was applied to 3 of the 15 replicates from the temperature program of 
Method 2 and the 3 replicates of the modified temperature program from Method 3 (See Table 
15).  For the paired t-test, if the t table value was higher than 0.05, the null hypothesis was 
rejected meaning there was not a significant difference between the retention times of the 
alkanes.  The paired t-test showed that alkanes C29-C33 were significantly different (p < 0.05, 
marked in bold) while the other alkanes were not significantly different.  The alkanes that eluted 
later showed a slightly larger variation compared to the rest of the alkanes.  Also, the retention 
times of the alkanes from the modified temperature program were slightly longer of about 0.01 
minutes compared to the retention times of the ladder  using Method 2.    
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Table 13. Intra-day variability of retention times of 3 replicates of  the hydrocarbon ladder using Method  3 parameters.  
 
C10 C11 C12 C13 C14 C15 C16 C17 C18 C19 C20 C21 
Average 3.62 4.85 6.18 7.53 8.83 10.09 11.29 12.43 13.51 14.55 15.54 16.49 
SD 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
%RSD 0.00 0.00 0.00 0.08 0.07 0.00 0.05 0.00 0.00 0.00 0.00 0.00 
 
 C22 C23 C24 C25 C26 C27 C28 C29 C30 C31 C32 C33 
Average 17.40 18.27 19.11 19.92 20.69 21.46 22.35 23.39 24.64 26.16 28.03 30.33 
SD 0.01 0.00 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.02 














Table 14. Student t-test at 95% confidence interval for hydrocarbon ladder comparing Method 2 and Method 3 parameters. 
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Table 15. Paired t-test at 95% confidence interval for hydrocarbon ladder comparing Method 2 and Method 3 parameters 
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Linear retention index Data- Shimadzu GC 
Each data set contained three replicates of the hydrocarbon ladder and three replicates of 
each of the nine drug standards.  The ladder retention times were averaged for the three runs and 
used to calculate LRI for each set of data.  The retention index of each drug was calculated three 
times (one per each retention time for each drug) and then averaged (See Table 16).  The 
averaged LRI is seen below in the table.   
Table 16. Combined linear retention index data on the Shimadzu GC.  Each Day three replicates 
were done.  Average of the retention indices are shown. Note that six significant figures were 
retained as per standard rules of rounding even though RIs are typically reported to whole 
numbers. 
Drug Samples Day 1 Day 2 Day 3 Day 4 Day 5 
Methamphetamine 1192.90 1193.39 1207.23 1193.51 1193.34 
D-Amphetamine 1137.99 1141.49 1144.06 1141.46 1139.49 
Phentermine 1191.80 1193.19 1188.64 1175.12 1174.49 
Pentobarbital 1764.87 1765.65 1765.80 1767.27 1766.76 
Butabarbital 1686.27 1687.24 1687.55 1688.95 1688.42 
Phenobarbital 2006.44 2007.89 2007.72 2008.07 2007.30 
Heroin 2707.75 2709.28 2709.31 2710.33 2709.32 
Oxycodone 2623.96 2625.96 2626.31 2627.44 2626.32 
Codeine 2477.42 2479.61 2479.43 2480.54 2479.97 
 
The first two runs of methamphetamine and phentermine yielded LRI values that are 
more similar than expected.  The third run showed a larger difference between the two which 
was more expected.  The same samples were used for the first two runs on the Shimadzu GC and 
on the PerkinElmer GC. The LRI of methamphetamine and phentermine were about 20 riu apart 
each day that was evaluated (100 ppm).  Peak fronting was exhibited at 100 ppm in 
methamphetamine (See Figure 21) and phentermine (See Figure 23) in the Shimadzu GC, which 
accounted for the smaller difference in LRI between the two.  The values in bold are the values 
where the peak fronting was exhibited.  A thicker film thickness has a higher mass transfer term 
according to the van Deemter equation. Since there is a higher capacity for interactions between 
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the analyte and the thicker stationary phase, generally a higher concentration can be efficiently 
separated using a thicker film.  However, in the case of methamphetamine and phentermine, a 
higher concentration caused the column to overload and influenced the retention times which 
affected the linear retention index. The concentrations were lowered to 10 ppm to avoid peak 
fronting both drugs (See Figure 22 and 24).   
 
 
Figure 21.  Methamphetamine chromatograph at 100 ppm.  Showed signs of peak fronting 













Figure 23.  Phentermine peak at 100 ppm.  Showed signs of peak fronting which is an indication 
of overloading   
.   
 





 The uncertainty for each drug was calculated to find an acceptable range of LRI.  
Methamphetamine and phentermine have higher ranges due to overloading the column (See 
Table 17). While this problem was easily corrected as discussed below, such overloading could 
occur during rapid drug screening methods in forensic labs and clearly must be avoided if LRI 
values are to be used. 
Table 17. Uncertainty range for stimulant on the Shimadzu GC 
 Methamphetamine D-Amphetamine Phentermine 
Average 1196 1141 1185 
SD 6 2 9 
Samples Size 15 15 15 
Uncertainty/Std. Error 2 1 2 
df 14 14 14 
t-value 2.14 2.14 2.14 
95% Conf Dev. 3 1 5 
CI max 1199 1142 1189 
CI min 1193 1140 1180 










 Nine samples of phentermine and three samples of methamphetamine were run again at 
10 ppm. The new values replaced the values in bold from Table 16.  The values are the average 
of three runs (See Table 18).  
Table 18. Modified combined data for methamphetamine and phentermine on the Shimadzu GC.  
Each Day three replicates were done.  Average of the retention indices are shown.  **Data for 
phentermine and methamphetamine were corrected.   
Drug Samples Day 1 Day 2 Day 3 Day 4 Day 5 
Methamphetamine 1192.90 1193.39 1195.59 1193.51 1193.34 















 The uncertainty for each drug was calculated to find an acceptable range of LRI for 
methamphetamine and phentermine without overloading the column.  The range has decreased 
and the standard deviation is smaller compared to Table 15 (See Table 19). The uncertainty 
ranges for barbitals (See Table 20) and depressants (See Table 21) were also found.   




Average 1194 1176 
SD 1 1 
Samples Size 15 15 
Uncertainty/Std. Error 0.3 0.3 
df 14 14 
t-value 2.14 2.14 
95% Conf Dev. 0.5 0.7 
CI max 1194 1177 
CI min 1193 1176 















Table 20. Uncertainty range for barbitals on the Shimadzu GC 
 Pentobarbital Butabarbital Phenobarbital 
Average 1766 1688 2007 
SD 1 1 1 
Samples Size 15 15 15 
Uncertainty/Std Error 0 0 0 
df 14 14 14 
t-value 2.14 2.14 2.14 
95% Conf Dev. 0.5 0.5 0.3 
CI max 1767 1688 2008 
CI min 1766 1687 2007 




Table 21. Uncertainty range for depressants on the Shimadzu GC 
 Heroin Oxy Codeine 
Average 2709 2626 2479 
SD 1 1 1 
Samples Size 15 15 15 
Uncertainty/Std Error 0 0 0 
df 14 14 14 
t-value 2.14 2.14 2.14 
95% Conf Dev. 0.5 0.7 0.6 
CI max 2710 2627 2480 
CI min 2709 2625 2479 





Linear retention Index Data- PerkinElmer GC 
 The LRI for the PerkinElmer showed little variation. Often, the retention times were 
identical within each day (See Table 22).  The uncertainty values were found for each group of 
drugs (See Table 23, 24,and 25). 
Table 22. Combined linear retention index data on the PerkinElmer GC.  Each Day three 
replicates were done.  Average of the retention indices are shown 
Drug Samples Day 1 Day 2 Day 3 Day 4 Day 5 
Methamphetamine 1190.58 1190.48 1190.23 1190.98 1191.46 
D-Amphetamine 1132.58 1133.08 1132.83 1133.08 1132.83 
Phentermine 1168.69 1169.17 1168.42 1168.92 1168.94 
Pentobarbital 1763.00 1762.39 1762.39 1762.39 1762.69 
Butabarbital 1682.46 1682.17 1681.87 1682.46 1682.46 
Phenobarbital 1996.31 1996.97 1995.96 1998.32 1996.97 
Heroin 2719.70 2719.70 2720.83 2720.83 2720.22 
Oxycodone 2610.39 2610.39 2610.39 2611.69 2610.09 
Codeine 2455.00 2455.56 2455.15 2455.97 2455.56 
 




Table 23.Uncertainty range for stimulants on the PerkinElmer GC 
 
Methamphetamine D-amphetamine Phentermine 
Average 1191 1133 1169 
SD 1 0 0 
Samples Size 15 15 15 
Uncertainty 0.2 0.1 0.1 
df 14 14 14 
t-value 2.14 2.14 2.14 
95% Conf Dev. 0.5 0.2 0.2 
CI (+) 1191 1133 1169 
CI (-) 1190 1133 1169 





Table 24. Uncertainty range for barbitals on the PerkinElmer GC 
 Pentobarbital Butabarbital Phenobarbital 
Average 1763 1682 1997 
SD 0 0 1 
Samples Size 15 15 15 
Uncertainty 0.1 0.1 0.2 
df 14 14 14 
t-value 2.14 2.14 2.14 
95% Conf Dev. 0.2 0.2 0.5 
CI (+) 1763 1682 1998 
CI (-) 1762 1682 1997 





Table 25. Uncertainty range for depressants on the PerkinElmer GC 
 Heroin Oxycodone Codeine 
Average 2720 2611 2455 
SD 1 1 1 
Samples Size 15 15 15 
Uncertainty 0.2 0.2 0.1 
df 14 14 14 
t-value 2.14 2.14 2.14 
95% Conf Dev. 0.4 0.4 0.3 
CI (+) 2721 2611 2456 
CI (-) 2720 2610 2455 




 The LRI for each drug group was calculated and averaged for three replicates from the 
average ladder from the modified temperature program from Method 2 (Table 26,27, and 28).  
The LRI of the 9 drugs found were all within the uncertainty range found for each drug using the 
parameters from Method 1 (or within 1 riu) suggesting that the differences between the two 
















Table 26. LRI data for stimulants on the PerkinElmer GC using Method 3 parameters 
 
Methamphetamine D-Amphetamine Phentermine 
Run 1 1189 1132 1168 
Run 2 1189 1132 1168 
Run 3 1190 1132 1168 
    
Average 1189 1132 1168 
SD 0.8 0.0 0.4 





















Table 27. LRI data for barbitals on the PerkinElmer GC using Method 3 parameters 
 Pentobarbital Butabarbital Phenobarbital 
Run 1 17623 1681 1997 
Run 2 1763 1681 1997 
Run 3 1763 1682 1997 
 
   
Average 1763 1681 1997 
SD 0.00 0.5 0.00 






















Table 28. LRI data for depressants on the PerkinElmer using Method 3 parameters 
 Heroin Oxycodone Codeine 
Run 1 2720 2610 2456 
Run 2 2720 2612 2454 





Average 2720 2611 2455 
SD 0.00 0.7 0.7 




Combined LRI data from the Shimadzu GC and the PerkinElmer GC 
 
 A one-way ANOVA was calculated for each drug from both instruments.  Every drug 
had an F value higher than the Fcritical value and a p-value less than 0.05, which rejects the null 
hypothesis that the means are the same. Based on a one-way ANOVA, the LRI data cannot be 
combined for the both instruments.  An example of the one-way ANOVA table is shown below 
for pentobarbital (See Table 29).  
Table 29. One-way ANOVA table for pentobarbital from both instruments 
Source of 
Variation 
SS df MS F P-value F crit 
Between Groups 91.47 1 91.47 195.28 3.78 x 10
-14
 4.20 
Within Groups 13.11 28 0.47 
   
       
Total 104.59 29 





Resolution study for methamphetamine and phentermine 
 
 Methamphetamine and Phentermine were equally combined and run through both the 
Shimadzu GC and PerkinElmer GC at concentrations of 10 ppm and 100 ppm.  The temperature 
ramp programs were the same (Method 1 and Method 3).  The resolution of peaks was calculated 
to determine if the peaks were fully separated.  The PerkinElmer at 10 ppm and 100 ppm (See 
Figure 27 and 28) and 10 ppm on Shimadzu (See Figure 25) were fully resolved while the 
100ppm on the Shimadzu was not (See Figure 26).   
 The linear retention indices were calculated for the 100 ppm methamphetamine and 
amphetamine mixture for the Shimadzu GC (See Table 30).  The LRI do show a difference 
between the two drugs where the resolution of the peaks did not.   
Table 30. LRI of 10 ppm mixture of methamphetamine and phentermine on the Shimadzu GC 
 
Methamphetamine Phentermine 
Run 1 1200.75 1181.39 
Run 2 1201.84 1183.71 
Run 3 1201.91 1184.25 
   
Average 1201.50 1183.12 
SD 0.65 1.52 










Figure 25. Methamphetamine and phentermine at 10 ppm on the Shimadzu GC 
 
 





Figure 27. Methamphetamine and phentermine at 10 ppm on the PerkinElmer GC 
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When the hydrocarbon ladder was run on the Shimadzu GC, the alkane ladder spanned 
C7-C29 and eventually C8-C29 after an adjustment to the start time on the MS to incorporate a 
solvent delay.  The PerkinElmer GC spanned C10-C33.  The temperature ramp programs were 
the same with only a difference in the injector port temperature (30°C lower in PerkinElmer GC) 
and the interface temperature (10°C).  A second experiment using the same experimental 
conditions were performed on the PerkinElmer and the same linear alkanes were detected, C10-
C33.  This indicates that the injector port temperature and interface temperature is not 
influencing the amount of alkanes seen in each GC.   
One explanation for more alkanes seen later in the PerkinElmer GC is due to the thinner 
film thickness of the column.  It is possible that the alkanes are not retained as much as they are 
in the thicker film of the column in the Shimadzu GC.  The earlier alkanes not shown are 
believed to elute during the solvent delay of 3 minutes. Since there is less interaction with the 
thinner film, it is possible that more of the beginning alkanes (C7, C8, and C10) are not seen in 
the PerkinElmer GC compared to the thicker film in the Shimadzu GC.    
The hydrocarbon ladders were run for approximately a month.  The hydrocarbon ladders 
for the Shimadzu GC and the PerkinElmer GC did show a difference in the variances of the 
means, therefore a hydrocarbon ladder should be run at least once before running any drug 
samples for the same day.   
The film thickness of the Restek
® 
column in the Shimadzu GC is double that of the 
Phenomenex
®
 column in the PerkinElmer GC.  Methamphetamine and phentermine had to be 
diluted more to 10 ppm in order to have a more Gaussian shape.  When the LRI was calculated 
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between these two drugs, the LRI was very nearly identical in some cases at 100 ppm.  For the 
first two sets of data, methamphetamine was run at 10 ppm while phentermine was run at 100 
ppm.  New samples were made up to 100 ppm so the third set of data had both drugs run at 100 
ppm for the third day of sampling.  While the LRI is expected to be closer, the two drugs should 
have a larger difference that what was being calculated.  Both compounds at 100 ppm exhibited 
peak fronting in the first three sets of data for the Shimadzu GC.  The concentration was lowered 
to 10ppm for each compound for the fourth and fifth sets of data to avoid peak fronting.  After 
the adjustment of phentermine to 10 ppm, the peak was no longer showing peak fronting.  There 
was not any peak fronting for these two compounds with the Phenomenex
® 
column in the 
PerkinElmer GC at 100ppm so the concentration remained the same for the five runs on that 
instrument.   
When the phentermine and methamphetamine were run at 10 ppm, no peak fronting was 
seen.  When this correction is not made, the LRI values are too similar to be differentiated.  Care 
should be taken in indicating peak fronting is not shown in any of the peaks since it does 
influence the calculation of LRI.  The variability was much lower when these two drugs were run 
at a lower concentration.  There were also about 20 riu apart which is to be expected from 
previous literature.   
The PerkinElmer GC showed a smaller variation of the retention times of the nine drugs 
samples.  Often the retention times were identical between data sets. This indicates that a thinner 
film thickness for a DB-5 equivalent stationary phase is ideal. The equilibrium time was double 
that of the Shimadzu GC, meaning that it had more time to equilibrate the temperature of the 
column.  This also could account for the small variability of retention times.   When the mixture 
of methamphetamine and phentermine was examined, sufficient resolution was still obtained.  
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However, the mass spectrum and library search produce similar results.  This could indicate a 
false positive when using a mass spectrometer to identify methamphetamine and phentermine.  
Even when mixed together, retention indices were able to differentiate the drugs when the peaks 
were not fully resolved.   
The modified temperature program used from Method 3 for the PerkinElmer GC 
suggested that the LRI values could be combined with the LRI data using Method 2 for the 
PerkinElmer GC.  Even though some alkanes were significantly different (t-test, 95% 
confidence) from the hydrocarbon ladder with 15 replicates, it did not influence LRI because 
those alkanes were not used for the calculation of LRI.  However, this test only applies when the 
variance is measurable.  More replication using the parameters from Method 3 would need to be 
completed before stating that the two data sets could be safely combined.  
Using a paired t-test, the hydrocarbon ladders from Method 2 and Method 3 were not 
significantly different.  The alkanes C29-C33 were significantly different but these alkanes spend 
more time in the column and have a slightly larger variability. If these alkanes are used to find 
RI, the conditions should be exactly the same for comparison.   It is suggested that the change in 
interface and injection port temperature did not influence that two data sets on the PerkinElmer 
GC since the LRI calculated using the modified temperature program did fall within the 
uncertainty range for each drug (or within 1 riu).   Regardless, the LRI values between the two 
instruments (Shimadzu GC and PerkinElmer GC) cannot be combined.    
Uncertainty values were generated for each drug on each GC.  This could increase the 
value of LRI when the same column and experimental parameters are used in other laboratories.  
Film thickness of the same stationary phase is known to affect LRI.  It was shown through this 
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study that the data cannot be combined. However, some of the uncertainty ranges are within 10 
riu (the drugs that eluted before 12 minutes) while others are over 40 riu apart.   LRI is reported 
in the NIST database.  However, the values are often estimated and much higher than the actual 
values.  In order for LRI to be used and compared, the same experimental parameters must be 
used.  Each peak needs to be examined for peak fronting or the LRI value will not be accurate.  
For a universal database to be used (i.e., one that could be used amongst and between 
laboratories), standardization on the two most common columns used in drug analysis (DB-1 and 
DB-5 equivalents) must be performed.  If the same experimental conditions are used, the data 
should be comparable.  An amine column may be better suitable for drug analysis for LRI since 
most drugs are basic.  Overall, LRI can separate samples that co-elute which can prevent false 
positives as well as false negatives. Also, since this method is rapid and simple, it can aid in 
backlog which would benefit the forensic community, specifically drug analysis, immensely.  
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**Two peaks of heroin were seen on both instruments.  This is due to degradation of the 
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